|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.7 SEK | -.--% |
|
+3.64% | +14.00% |
| Feb. 22 | ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
| 2023 | ODI Pharma Sells CBD Skincare Brand for SEK3 Million | MT |
ODI Pharma AB (publ) reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported sales was SEK 0.028006 million. Revenue was SEK 0.045861 million compared to SEK 0.000317 million a year ago.
Net loss was SEK 1.6 million compared to SEK 1.18 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.00% | 7.94M | |
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B |
ODI PHARMA AB 
